Loading patent…
OwnerMark S. Berger, Tona Morgan Gilmer +4inventors
InventorsMark S. Berger, Tona Morgan Gilmer, Arundathy Nirmalini Pandite, David Rusnak, Neil L. Spector, Iman El-Hariry
Estimating the term…
The present invention relates to a method of treating cancer in a mammal by administration of 4-quinazolinamines and pharmaceutical compositions containing the same. In particular, the method relates to a methods of treating cancers which are mediated by the tyrosine kinases EGFR and/or erbB2 by administration of N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine and salts and solvates thereof.
A method of treating an EGFR and/or erbB2 overexpressing cancer in a mammal, comprising:
A method of treating an EGFR overexpressing cancer in a mammal, comprising:
A method of treating an erbB2 overexpressing cancer in a mammal, comprising:
A method of treating an EGFR and erbB2 overexpressing cancer in a mammal, comprising:
A method of treating renal cancer in a mammal, comprising:
A method of treating urothelial cancer in a mammal, comprising:
Dependencies are inferred from the claim text.